Aquilo Capital Management
Aquilo Capital invests in drug development companies that harness the power of cutting-edge science to address urgent medical needs. We employ deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. In our view, these investment opportunities offer both substantial risk-adjusted returns as well as paradigm-changing therapeutics for patients and for society. Marc Schneidman, Founder & CIO, has over 20 years of dedicated investing experience across the biotechnology universe.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Aquilo Capital Management
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- CS
Christian Sirko
Research Analyst · Finance & Accounting
EmailPhone - BP
Brian Polzak
Co-founder · General Business & Management
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Aquilo Capital Management
3 distinct titles indexed · top 3 shown.
- 1co-founder
- 1isso
- 1research analyst
Sign up to unlock all 3 contacts at Aquilo Capital Management
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Aquilo Capital Management
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.